These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2859304)

  • 41. Quazepam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in insomnia.
    Ankier SI; Goa KL
    Drugs; 1988 Jan; 35(1):42-62. PubMed ID: 2894293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiclinic double-blind comparison of triazolam and flurazepam for seven nights in outpatients with insomnia.
    Fabre LF; Gross L; Pasigajen V; Metzler C
    J Clin Pharmacol; 1977 Jul; 17(7):402-9. PubMed ID: 18492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can a rapidly-eliminated hypnotic cause daytime anxiety?
    Adam K; Oswald I
    Pharmacopsychiatry; 1989 May; 22(3):115-9. PubMed ID: 2748714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical pharmacokinetics of the newer benzodiazepines.
    Greenblatt DJ; Divoll M; Abernethy DR; Ochs HR; Shader RI
    Clin Pharmacokinet; 1983; 8(3):233-52. PubMed ID: 6133664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic properties of benzodiazepine hypnotics.
    Greenblatt DJ; Abernethy DR; Divoll M; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 1983 Apr; 3(2):129-32. PubMed ID: 6132931
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The clinical use of hypnotics: indications for use and the need for a variety of hypnotics.
    Rickels K
    Acta Psychiatr Scand Suppl; 1986; 332():132-41. PubMed ID: 2883820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Controlled clinical study on the effect of quazepam versus triazolam in patients with sleep disorders].
    Altamura AC; Colacurcio F; Mauri MC; De Vanna M; Rigamonti R; Maj M; Veltro F; Pancheri P; Delle Chiaie R; Porta M
    Minerva Psichiatr; 1989; 30(3):159-64. PubMed ID: 2691808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of triazolam, flurazepam, and placebo as hypnotics in geriatric patients with insomnia.
    Reeves RL
    J Clin Pharmacol; 1977; 17(5-6):319-23. PubMed ID: 16041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical uses and advantages of low doses of benzodiazepine hypnotics.
    Vogel G
    J Clin Psychiatry; 1992 Jun; 53 Suppl():19-22. PubMed ID: 1613015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose determinants of rebound insomnia.
    Roehrs TA; Zorick FJ; Wittig RM; Roth T
    Br J Clin Pharmacol; 1986 Aug; 22(2):143-7. PubMed ID: 3530302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preference studies of triazolam with standard hypnotics in out-patients with insomnia.
    Fabre LF; McLendon DM; Harris RT
    J Int Med Res; 1976; 4(4):247-54. PubMed ID: 16801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Midazolam vs lorazepam and placebo as hypnotic premedication before surgery. A controlled, double-blind study.
    Mattila MA; Salmela J; Väänänen A; Kylmämaa T
    Drugs Exp Clin Res; 1985; 11(12):841-4. PubMed ID: 2873011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rebound insomnia and hypnotic self administration.
    Roehrs T; Merlotti L; Zorick F; Roth T
    Psychopharmacology (Berl); 1992; 107(4):480-4. PubMed ID: 1603890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short acting benzodiazepines.
    O'Donovan MC; McGuffin P
    BMJ; 1993 Apr; 306(6883):945-6. PubMed ID: 8098236
    [No Abstract]   [Full Text] [Related]  

  • 55. Anxiety caused by a short-life hypnotic.
    Morgan K; Oswald I
    Br Med J (Clin Res Ed); 1982 Mar; 284(6320):942. PubMed ID: 6121606
    [No Abstract]   [Full Text] [Related]  

  • 56. Lorazepam-efficacy, side effects, and rebound phenomena.
    Scharf MB; Kales A; Bixler EO; Jacoby JA; Schweitzer PK
    Clin Pharmacol Ther; 1982 Feb; 31(2):175-9. PubMed ID: 6120058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Double-blind comparison of lormetazepam and flurazepam in the treatment of patients with insomnia].
    De Anna M; Zucconi M; Baruzzi A; Cirignotta F; Gallassi R; Soverini S
    Farmaco Prat; 1982 Sep; 37(9):275-81. PubMed ID: 6128249
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse reactions to triazolam, flurazepam, and placebo in controlled clinical trials.
    Greenblatt DJ; Shader RI; Divoll M; Harmatz JS
    J Clin Psychiatry; 1984 May; 45(5):192-5. PubMed ID: 6144670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.